Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05120635 · ClinicalTrials.gov registry record · NA
Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans
A NA study of PTSD and Fear, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT05120635: Recruiting NA study of PTSD and Fear, sponsored by Duke University.
NCT05120635 is a NA study of PTSD and Fear that is actively recruiting participants, run by Duke University. The registered enrollment target is 80 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05120635, a NA study of PTSD and Fear, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
Anxiety disorders such as post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD) affect a large number of individuals with a significant portion of patients failing to improve with current treatments. The purpose of this study is to understand the brain mechanisms that produce fear and anxiety in humans. To accomplish this goal, we will measure the brain activity along with the heart rate and skin perspiration of patients while they are completing tasks on a computer. Some of the tasks will also use a virtual reality headset and transport the patient in a video game-like environment. These tasks will expose the participants to various levels of fear-provoking images. Participants with responsive neurostimulation (RNS) implants will be enrolled under Pro00117931 at Duke, but their results for fear and anxiety tasks will be reported under NCT05120635.
Primary Outcome
Eye blinks will be measured using an eye tracking device and will be measure in blinks per second.
Conditions Studied
Interventions
- DEVICE Deep Brain Stimulation
- BEHAVIORAL Virtual and augmented reality tasks
Study Locations (2)
California
- University of California Los Angeles - Los Angeles
North Carolina
- Duke University Health System - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT05120635 shows while recruiting
NCT05120635 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (73% lower).
The record links to 4 conditions, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which Deep Brain Stimulation is the first listed.
NCT05120635 reports a single indexed study location in California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT05120635 about?
NCT05120635 is a clinical study titled "Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans". Anxiety disorders such as post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD) affect a large number of individuals with a significant portion of patients failing to improve with current treatments. The purpose of this study is to understand the brain mechanisms that produce...
What is the current status of trial NCT05120635?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2021-10-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05120635 study?
This clinical trial studies the following conditions: PTSD, Fear, GAD, Emotional Memory.
What interventions are being tested in trial NCT05120635?
The interventions under investigation include: Deep Brain Stimulation (DEVICE), Virtual and augmented reality tasks (BEHAVIORAL).
Who is sponsoring clinical trial NCT05120635?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05120635 being conducted?
This trial has 2 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05120635's enrollment target sits among peer trials
80 73rd of 154 higher than 79 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI